1. $EXEL on watch

  2. #stocks what moves aftermarket http://y.ahoo.it/W8IDAWJ2 $EXEL $VPHM

  3. MACD cross-down $MNJA $EXEL $RJA $RPAI $GOLD $GGN $BRD $H $LBAS $RLOC $TGC $CFNL $PDII $TLP $CCCL

  4. Shares of $EXEL crossed below the 200-day moving average. http://y.ahoo.it/KowcbmaZ

  5. Useful explanations presented in relation to $EXEL conference call transcript http://y.ahoo.it/fz1Z3kJ5

  6. $GEVO I would recommend playing $EXEL which is a better yoyo

  7. $EXEL Exelixis Announces Webcasts of Upcoming Investor Conference Presentations.. http://y.ahoo.it/4A17ARyz

  8. @bradloncar Was there any real change in tone, positive/negative, from $EXEL s presentation at ASCO?

  9. Shares of $EXEL touched and failed to cross below the 50-day moving average.

  10. $EXEL I like this chart to base/consolidate for a break of 5.

  11. $EXEL s p3 in hepatocellular carcenoma is scheduled to initiate Q3. The renal cell carcenoma trial just initiated as well of course. #ASCO13

  12. Listen to $EXEL Exelixis, Inc. at American Society of Clinical Oncology (ASCO) 2 - live at 07:00 PM, ondemand after - http://y.ahoo.it/XjBgDZVu

  13. Heading into the $EXEL investor briefing. Have to support cometriq because it s made in Kansas City. #ASCO13

  14. $ALXA $ARNA $EXEL $DNDN $MNKD $NAVB $SNTA $SQNM $ZIOP #Biotech short squeeze potential to watch.

  15. $EXEL Exelixis Presents COMETRIQ™ (cabozantinib) Clinical Trial Data in Patients w.. http://y.ahoo.it/J5ePqY1e

  16. @BiotechMoney18: $$$ 6/3 BIOTECH watchlist: $ACHN $RMTI $TEAR $MNKD $FLML $DEPO $CUR $CBRX $ARQL $NKTR $EXEL $ZIOP $$$

  17. @BiotechMoney18: $$$ 6/3 BIOTECH watchlist: $ACHN $RMTI $TEAR $MNKD $FLML $DEPO $CUR $CBRX $ARQL $NKTR $EXEL $ZIOP $$$

  18. $$$ 6/3 BIOTECH watchlist: $ACHN $RMTI $TEAR $MNKD $FLML $DEPO $CUR $CBRX $ARQL $NKTR $EXEL $ZIOP $$$

  19. $EXEL http://y.ahoo.it/HPdzjlcF from http://y.ahoo.it/dmVoDize

  20. $EXEL Exelixis Announces Presentation of Updated Phase 2 Data for Cabozantinib in .. http://y.ahoo.it/n0bbGqqE

  21. $EXEL going for 5 dolla holla $$

  22. $EXEL announced the initiation of a phase 3 for cabo in metastatic renal cell carcinoma. I ll be attending their analyst event Sun afternoon

  23. $EXEL Exelixis Initiates Phase 3 Pivotal Trial of Cabozantinib in Patients With Me.. http://y.ahoo.it/6qTNXuwv

  24. New analyst recommendations on $AEGR $ADS $EXEL http://y.ahoo.it/YK6aV0Ad

  25. Maxim Group Downgrades Exelixis ($EXEL) to Hold http://y.ahoo.it/8yAHxZMd